COVID-19 in patients with myasthenia gravis.

Pria AnandMichaël C C SlamaMichelle KakuCharlene OngAnna M Cervantes-ArslanianLan ZhouWilliam S DavidAmanda C Guidon

Published in: Muscle & nerve (2020)

Our findings suggest that the clinical course and outcomes in patients with MG and COVID-19 are highly variable. Further large studies are needed to define best practices and determinants of outcomes in this unique population.

Keyphrases

coronavirus disease
sars cov
myasthenia gravis
primary care
type diabetes
metabolic syndrome